Phage MuA Transposase Market Expected to Reach New Heights by 2035
The global Phage MuA Transposase Market is entering a dynamic phase of expansion, offering transformative opportunities for manufacturers and biotechnology developers worldwide. Valued at USD 321.1 million in 2025 , the market is projected to soar to USD 726.0 million by 2035 , achieving a compound annual growth rate (CAGR) of 8.5% . From its 2021 valuation of USD 213.5 million, the market’s steady rise underscores the accelerating demand for advanced molecular biology tools essential to biopharmaceutical research, genetic engineering, and therapeutic innovation . A Decade of Consistent Growth and Innovation Between 2026 and 2030, the Phage MuA Transposase Market is expected to expand from USD 321.1 million to USD 482.8 million , followed by a strong progression toward USD 726.0 million by 2035 . This acceleration is driven by the growing adoption of MuA transposase-based tools across gene therapy, genome edit...